Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats

H. Zhou, Y. F. Ma, Wei Yao, L. Cui, R. Setterberg, C. T. Liang, W. S S Jee

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Previously we found that PGE2 3 mg/kg in 20-month-old male rats induced massive bone formation mainly by modeling dependent bone gain in cortical bone. It is not known whether cancellous bone will respond similarly; thus, we evaluated the effect of PGE2 on cancellous bone of the same aged rats. Thirty-four 20-month-old Wistar male rats were given PGE2 (3 mg/kg/day) or vehicle subcutanously for 10 and 30 days. Double fluorescent labels were injected 9 and 2 days prior to the sacrifice. Histomorphometry was performed on 1% toluidine blue stained and unstained sagittal sections of lumbar vertebral bodies. The results demonstrated that 10-day PGE2 treatment increased osteoprogenitor cells, osteoblasts (×2-fold), osteoid (×4.5-fold), woven bone formation (0.04%), and 40% more trabecular area; it stimulated modeling (×2-fold) and remodeling-dependent (×1.5-fold) bone formation with increase of mineralization lag time (MLT, × 7.5-fold). Thirty-day treatment sustained increases in osteoblast numbers, modeling, and remodeling-dependent bone formation and further stimulated woven bone formation (6.6%), turnover (×3-fold), and trabecular area and number (×2-fold). Osteoprogenitor cells were undetectable along with 70% less osteoid area compared with 10-day treatment but still was 1.5-fold higher than aging controls. MLT returned to aging control level. It was concluded that the aged cancellous bone of 20-month-old male Wistar rat retains a capability of responding to the anabolic effect of PGE2. Osteoblastogenesis and enhanced modeling and remodeling-dependent woven or lamellar formation contribute to this anabolic action. Bone formation differed in that the endocortical surface of cortical bone was stimulated mainly by modeling whereas both modeling and remodeling-dependent bone gain were equally stimulated at the trabecular surface of the lumbar vertebral body.

Original languageEnglish (US)
Pages (from-to)179-184
Number of pages6
JournalCalcified Tissue International
Volume68
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Bone Remodeling
Dinoprostone
Osteogenesis
Osteoblasts
Wistar Rats
Anabolic Agents
Tolonium Chloride
Cancellous Bone
Bone and Bones

Keywords

  • Histomorphometry
  • Lumbar vertebra
  • Modeling
  • Prostaglandin E
  • Remodeling

ASJC Scopus subject areas

  • Endocrinology

Cite this

Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats. / Zhou, H.; Ma, Y. F.; Yao, Wei; Cui, L.; Setterberg, R.; Liang, C. T.; Jee, W. S S.

In: Calcified Tissue International, Vol. 68, No. 3, 2001, p. 179-184.

Research output: Contribution to journalArticle

@article{e109d9e923214cb0bef98108356e454a,
title = "Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats",
abstract = "Previously we found that PGE2 3 mg/kg in 20-month-old male rats induced massive bone formation mainly by modeling dependent bone gain in cortical bone. It is not known whether cancellous bone will respond similarly; thus, we evaluated the effect of PGE2 on cancellous bone of the same aged rats. Thirty-four 20-month-old Wistar male rats were given PGE2 (3 mg/kg/day) or vehicle subcutanously for 10 and 30 days. Double fluorescent labels were injected 9 and 2 days prior to the sacrifice. Histomorphometry was performed on 1{\%} toluidine blue stained and unstained sagittal sections of lumbar vertebral bodies. The results demonstrated that 10-day PGE2 treatment increased osteoprogenitor cells, osteoblasts (×2-fold), osteoid (×4.5-fold), woven bone formation (0.04{\%}), and 40{\%} more trabecular area; it stimulated modeling (×2-fold) and remodeling-dependent (×1.5-fold) bone formation with increase of mineralization lag time (MLT, × 7.5-fold). Thirty-day treatment sustained increases in osteoblast numbers, modeling, and remodeling-dependent bone formation and further stimulated woven bone formation (6.6{\%}), turnover (×3-fold), and trabecular area and number (×2-fold). Osteoprogenitor cells were undetectable along with 70{\%} less osteoid area compared with 10-day treatment but still was 1.5-fold higher than aging controls. MLT returned to aging control level. It was concluded that the aged cancellous bone of 20-month-old male Wistar rat retains a capability of responding to the anabolic effect of PGE2. Osteoblastogenesis and enhanced modeling and remodeling-dependent woven or lamellar formation contribute to this anabolic action. Bone formation differed in that the endocortical surface of cortical bone was stimulated mainly by modeling whereas both modeling and remodeling-dependent bone gain were equally stimulated at the trabecular surface of the lumbar vertebral body.",
keywords = "Histomorphometry, Lumbar vertebra, Modeling, Prostaglandin E, Remodeling",
author = "H. Zhou and Ma, {Y. F.} and Wei Yao and L. Cui and R. Setterberg and Liang, {C. T.} and Jee, {W. S S}",
year = "2001",
doi = "10.1007/s002230001207",
language = "English (US)",
volume = "68",
pages = "179--184",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats

AU - Zhou, H.

AU - Ma, Y. F.

AU - Yao, Wei

AU - Cui, L.

AU - Setterberg, R.

AU - Liang, C. T.

AU - Jee, W. S S

PY - 2001

Y1 - 2001

N2 - Previously we found that PGE2 3 mg/kg in 20-month-old male rats induced massive bone formation mainly by modeling dependent bone gain in cortical bone. It is not known whether cancellous bone will respond similarly; thus, we evaluated the effect of PGE2 on cancellous bone of the same aged rats. Thirty-four 20-month-old Wistar male rats were given PGE2 (3 mg/kg/day) or vehicle subcutanously for 10 and 30 days. Double fluorescent labels were injected 9 and 2 days prior to the sacrifice. Histomorphometry was performed on 1% toluidine blue stained and unstained sagittal sections of lumbar vertebral bodies. The results demonstrated that 10-day PGE2 treatment increased osteoprogenitor cells, osteoblasts (×2-fold), osteoid (×4.5-fold), woven bone formation (0.04%), and 40% more trabecular area; it stimulated modeling (×2-fold) and remodeling-dependent (×1.5-fold) bone formation with increase of mineralization lag time (MLT, × 7.5-fold). Thirty-day treatment sustained increases in osteoblast numbers, modeling, and remodeling-dependent bone formation and further stimulated woven bone formation (6.6%), turnover (×3-fold), and trabecular area and number (×2-fold). Osteoprogenitor cells were undetectable along with 70% less osteoid area compared with 10-day treatment but still was 1.5-fold higher than aging controls. MLT returned to aging control level. It was concluded that the aged cancellous bone of 20-month-old male Wistar rat retains a capability of responding to the anabolic effect of PGE2. Osteoblastogenesis and enhanced modeling and remodeling-dependent woven or lamellar formation contribute to this anabolic action. Bone formation differed in that the endocortical surface of cortical bone was stimulated mainly by modeling whereas both modeling and remodeling-dependent bone gain were equally stimulated at the trabecular surface of the lumbar vertebral body.

AB - Previously we found that PGE2 3 mg/kg in 20-month-old male rats induced massive bone formation mainly by modeling dependent bone gain in cortical bone. It is not known whether cancellous bone will respond similarly; thus, we evaluated the effect of PGE2 on cancellous bone of the same aged rats. Thirty-four 20-month-old Wistar male rats were given PGE2 (3 mg/kg/day) or vehicle subcutanously for 10 and 30 days. Double fluorescent labels were injected 9 and 2 days prior to the sacrifice. Histomorphometry was performed on 1% toluidine blue stained and unstained sagittal sections of lumbar vertebral bodies. The results demonstrated that 10-day PGE2 treatment increased osteoprogenitor cells, osteoblasts (×2-fold), osteoid (×4.5-fold), woven bone formation (0.04%), and 40% more trabecular area; it stimulated modeling (×2-fold) and remodeling-dependent (×1.5-fold) bone formation with increase of mineralization lag time (MLT, × 7.5-fold). Thirty-day treatment sustained increases in osteoblast numbers, modeling, and remodeling-dependent bone formation and further stimulated woven bone formation (6.6%), turnover (×3-fold), and trabecular area and number (×2-fold). Osteoprogenitor cells were undetectable along with 70% less osteoid area compared with 10-day treatment but still was 1.5-fold higher than aging controls. MLT returned to aging control level. It was concluded that the aged cancellous bone of 20-month-old male Wistar rat retains a capability of responding to the anabolic effect of PGE2. Osteoblastogenesis and enhanced modeling and remodeling-dependent woven or lamellar formation contribute to this anabolic action. Bone formation differed in that the endocortical surface of cortical bone was stimulated mainly by modeling whereas both modeling and remodeling-dependent bone gain were equally stimulated at the trabecular surface of the lumbar vertebral body.

KW - Histomorphometry

KW - Lumbar vertebra

KW - Modeling

KW - Prostaglandin E

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=0035033173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035033173&partnerID=8YFLogxK

U2 - 10.1007/s002230001207

DO - 10.1007/s002230001207

M3 - Article

VL - 68

SP - 179

EP - 184

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 3

ER -